Canadian pharmaceutical company Scythian Biosciences Corp. named Michael Barnes to be chief medical officer.
Barnes, a clinical neurologist, is an honorary professor of neurological rehabilitation at the University of Newcastle.
Scythian Biosciences appoints chief medical officer
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Canadian pharmaceutical company Scythian Biosciences Corp. named Michael Barnes to be chief medical officer.
Barnes, a clinical neurologist, is an honorary professor of neurological rehabilitation at the University of Newcastle.